Involvement of opioid receptors in the antinociception produced by intracerebroventricularly administered spantide in mice

Neuropeptides
K Tan-NoK Kisara

Abstract

The antinociceptive effect of intracerebroventricularly (i.c.v.) administered [D-Arg1, D-Trp7,9, Leu11]-substance P (spantide), a non-selective tachykinin antagonist, was examined using the mouse formalin test. Licking behaviour induced by 2% formalin solution in the hindpaw of mice had two peaks, 0-5 min (first phase) and 10-30 min (second phase). I.c.v. spantide produced a dose-dependent antinociception during the first and second phases. The ID50 values were 2.95 (1.59-5.46) nmol for the first phase and 2.87 (1.49-5.52) nmol for the second phase. The antinociceptive effect in the first phase, but not in the second phase produced by spantide was antagonized by pretreatment with naloxone (1.0 mg/kg, i.p.), an opioid receptor antagonist. An opioid binding study using [3H]naloxone revealed that spantide was able to inhibit [3H]naloxone binding to mouse brain membrane preparations. These results suggest that opioid receptor systems in the mouse brain are involved in spantide-induced antinociception during the first phase, but not during the second phase of the formalin-induced nociceptive behaviour.

References

Oct 1, 1992·British Journal of Pharmacology·A NagahisaK Taniguchi
Aug 1, 1990·British Journal of Pharmacology·M Yanagisawa, M Otsuka
Mar 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·P A Johnston, L A Chahl
Jul 31, 1985·European Journal of Pharmacology·C Post, K Folkers
Nov 24, 1986·Life Sciences·H I JacobyJ L Vaught
Apr 1, 1987·Neuropeptides·T SakuradaE Munekata
Sep 1, 1989·Pain·Kenneth E McCarson, Barry D Goldstein
Aug 9, 1988·European Journal of Pharmacology·D J CalcagnettiM S Fanselow
Apr 27, 1988·European Journal of Pharmacology·H NakamuraT Kadokawa
Jun 1, 1985·Journal of Neuroscience Methods·S HunskaarK Hole
Jan 1, 1983·Peptides·M E Hall, J M Stewart
Oct 1, 1984·British Journal of Pharmacology·K FolkersS Leander
Jul 29, 1983·Biochemical and Biophysical Research Communications·K KangawaH Matsuo
Feb 1, 1993·Pharmacology, Biochemistry, and Behavior·T SakuradaK Kisara
Mar 1, 1957·British Journal of Pharmacology and Chemotherapy·T J HALEY, W G MCCORMICK
Jan 1, 1991·Neurochemistry International·S Guard, S P Watson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.